VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $679,000 | -73.2% | 100,000 | -61.0% | 0.10% | -67.5% |
| Q3 2022 | $2,536,000 | -9.4% | 256,696 | 0.0% | 0.31% | -26.8% |
| Q2 2022 | $2,798,000 | -3.6% | 256,696 | 0.0% | 0.42% | -26.9% |
| Q1 2022 | $2,903,000 | +57.0% | 256,696 | +34.1% | 0.58% | +73.4% |
| Q3 2020 | $1,849,000 | -15.6% | 191,426 | 0.0% | 0.34% | +57.3% |
| Q2 2020 | $2,190,000 | -29.5% | 191,426 | -36.1% | 0.21% | -51.1% |
| Q1 2020 | $3,106,000 | – | 299,800 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |